Retrieve available abstracts of 11 articles: HTML format
Single Articles
August 2025
CALERO-CACERES W, Balcazar JL Progress in phage therapy in response to antimicrobial resistance.
Virology. 2025;609:110578. PubMed
July 2025
CHENCHULA S, Atal S, Ghanta MK, Uppugunduri CR, et al Emerging variants of Mpox virus and tecovirimat resistance: Genomic insights and
implications for treatment strategies.
Virology. 2025;608:110532. PubMedAbstract available
March 2025
ZHANG C, Liu P, Li J, Han M, et al Adaptation of single molecule real time (SMRT) sequence technology for hepatitis
C virus genome sequencing and identification of resistance-associated
substitutions.
Virology. 2025;605:110481. PubMedAbstract available
February 2025
LIN P, Liu S, Cao Z, Zeng Y, et al An experimental study on the lytic bacteriophage MSP15 with wide-spectrum
targeting methicillin-resistant Staphylococcus aureus.
Virology. 2025;605:110452. PubMedAbstract available
December 2024
NUWAGABA J, Li JA, Ngo B, Sutton RE, et al 30 years of HIV therapy: Current and future antiviral drug targets.
Virology. 2024;603:110362. PubMedAbstract available
KUMAR N, Sharma S, Kumar R, Meena VK, et al Evolution of drug resistance against antiviral agents that target cellular
factors.
Virology. 2024;600:110239. PubMedAbstract available
November 2024
COSTA P, Pereira C, Romalde JL, Almeida A, et al A game of resistance: War between bacteria and phages and how phage cocktails can
be the solution.
Virology. 2024;599:110209. PubMedAbstract available
October 2024
LI Y, Zhang Y, Li A, Zhang T, et al Characterization of a novel lytic phage against methicillin resistance
Staphylococcus aureus in Hainan island.
Virology. 2024;600:110264. PubMedAbstract available
FABIANI M, Castro EF, Battini L, Rosas RA, et al Two thiosemicarbazones derived from 1-indanone as potent non-nucleoside
inhibitors of bovine viral diarrhea virus of different genotypes and biotypes.
Virology. 2024;598:110189. PubMedAbstract available
July 2024
ZHANG Y, Shao Y, You H, Shen Y, et al Characterization and therapeutic potential of MRABP9, a novel lytic bacteriophage
infecting multidrug-resistant Acinetobacter baumannii clinical strains.
Virology. 2024;595:110098. PubMedAbstract available
December 2023
BIALY D, Richardson S, Chrzastek K, Bhat S, et al Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does
not require permissive mutations to retain the replicative fitness in vitro and
in ovo.
Virology. 2023;590:109954. PubMedAbstract available